Peripheral atherosclerosis, diabetes and long-term resultsof coronary artery bypass grafting

Authors: А.N. Sumin, N.А. Bezdenezhnykh, А.V. Bezdenezhnykh, S.V. Ivanov, O.L. Barbarash

Company: Research Institute for Complex Issues of Cardiovascular Diseases, Siberian Branch of the Russian Academy of Sciences; Sosnovyy bul’var, 6, Kemerovo, 650002, Russian Federation


Keywords: diabetes mellitus peripheral atherosclerosis coronary artery bypass surgery long-term outcomes

Full text:  

 

References

1. Дедов И.И., Терехин С.А. Реваскуляризация мио- карда у больных сахарным диабетом. Сахарный диабет. 2010; 4: 18–23.

2. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur. Heart J. 2013; 34 (39): 3035–87.

3. Farkouh M.E., Domanski M., Sleeper L.A., Siami F.S., Dangas G., Mack M. et al. Strategies for multivessel revascularization in patients with diabetes. N. Engl. J. Med. 2012; 367: 2375–84.

4. Hakeem A., Garg N., Bhatti S., Rajpurohit N., Ahmed Z., Uretsky B.F. Effectiveness of percutaneous coronary intervention with drug-eluting stents compared with bypass surgery in diabetics with multivessel coronary disease: comprehensive systematic review and meta-analysis of randomized clinical data. J. Am. Heart Assoc. 2013; 2 (4): e000354.

5. Huang F., Lai W., Chan C., Peng H., Zhang F., Zhou Y., Teng S., Huang Z. Comparison of bypass surgery and drug-eluting stenting in diabetic patients with left main and/or multivessel disease: A systematic review and meta-analysis of randomized and nonrandomized studies. Cardiol. J. 2014. DOI: 10.5603/CJ.a2014.0036 [Epub ahead of print].

6. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G. TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J. Vasc. Surg. Disease (TASC II). 2007; 45: S5–S67.

7. Zhang H., Yuan X., Osnabrugge R.L., Meng D., Gao H., Zhang S., Rao C., Hu S., Zheng Z. Influence of diabetes mellitus on long-term clinical and economic outcomes after coronary artery bypass grafting. Ann. Thorac. Surg. 2014; 97 (6): 2073–9.

8. Ferreiro J.L., Angiolillo D.J. Diabetes and antiplatelet therapy in acute coronary syndrome. Circulation. 2011; 123 (7): 798–813.

9. Сумин А.Н., Безденежных Н.А., Иванов С.В., Барбараш О.Л., Барбараш Л.С. К вопросу о рис- ке послеоперационных осложнений коронар- ного шунтирования у пациентов с сахарным ди- абетом 2 типа. Бюллетень НЦССХ им. А.Н. Баку- лева РАМН. 2012; 5: 59–68.

10. Koochemeshki V., Salmanzadeh H.R., Sayyadi H., Amestejani M., Salehi Ardabili S. The effect of diabetes mellitus on short term mortality and morbidity after isolated coronary artery bypass grafting surgery. Int. Cardiovasc. Res. J. 2013; 7 (2): 41–5.

11. Sun Y., Lin Z., Ding W., Wei Q., Shi Y., Wang C. Preoperative glucose level has different effects on the endogenous extracellular matrix-related gene expression in saphenous vein of type 2 diabetic patients undergoing coronary surgery. Diab. Vasc. Dis. Res. 2014; 11 (4): 226–34.

12. Байракова Ю.В., Баздырев Е.Д., Казачек Я.В., Каличенко Н.А., Безденежных Н.А., Груздева О.В. и соавт. Прогностическая роль С-реактивного белка в прогрессировании атеросклероза через год после коронарного шунтирования. Кардио- логия. 2013; 53 (6): 40–5.

13. Байракова Ю.В., Григорьев А.М., Баздырев Е.Д., Казачек Я.В., Барбараш О.Л., Барбараш Л.С. Роль субклинического воспаления в развитии сер- дечно-сосудистых осложнений у пациентов по- сле коронарного шунтирования. Кардиология и сердечно-сосудистая хирургия. 2013; 6 (3): 18–22.

14. Petursson P., Herlitz J., Lindqvist J., Sjцland H., Gudbjцrnsdottir S. Prevalence and severity of abnormal glucose regulation and its relation to long-term prognosis after coronary artery bypass grafting. Coron. Artery Dis. 2013; 24 (7): 577–82.

15. Tennyson C., Lee R., Attia R. Is there a role for HbA1c in predicting mortality and morbidity outcomes after coronary artery bypass graft surgery? Interact. Cardiovasc. Thorac. Surg. 2013; 17 (6): 1000–8.

16. Subramaniam B., Lerner A., Novack V., Khabbaz K., Paryente-Wiesmann M., Hess P., Talmor D. Increased glycemic variability in patients with elevated preoperative HbA1C predicts adverse outcomes following coronary artery bypass grafting surgery. Anesth. Analg. 2014; 118 (2): 277–87.

17. Bangalore S., Toklu B., Feit F. Outcomes with coronary artery bypass graft surgery versus percutaneous coronary intervention for patients with diabetes mellitus: Can newer generation drug-eluting stents bridge the gap? Circ. Cardiovasc. Interv. 2014; 7 (4): 518–25.

18. Harskamp R.E., Walker P.F., Alexander J.H., Xian Y., Liberman H.A., De Winter R.J. et al. Clinical outcomes of hybrid coronary revascularization versus coronary artery bypass surgery in patients with diabetes mellitus. Eur. Heart J. 2014; 35 (Abstract Supplement): 525–6. Abstract: 2892.

Chief Editor

Leo A. Bockeria, MD, PhD, DSc, Professor, Academician of Russian Academy of Sciences, President of Bakoulev National Medical Research Center for Cardiovascular Surgery